2024 Annual Meeting | S19 - Epilepsy Clinical Trials and Long-term Studies

Date Monday 04/15/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Location Colorado Convention Center | 708/710/712

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Brin Freund, MD, Babak Razavi, MD, PhD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives A group of abstracts covering a similar topic will be presented in an eight-minute oral format followed by four minutes of question and answer with the author.

CME Available 2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:42 PM MDT	Speaker	2024 Dreifuss-Penry Epilepsy Award: This award recognizes physicians in the early stages of their careers who have made an independent contribution to epilepsy research. Erin C. Conrad, MD
03:42 PM - 03:54 PM MDT	Abstract	002 - First-in-Human Trial of NRTX-1001 GABAergic Interneuron Cell Therapy for Treatment of Focal Epilepsy - Emerging Clinical Trial Results Cory R. Nicholas, PhD
03:54 PM - 04:06 PM MDT	Abstract	003 - Efficacy and Safety of ES-481, a Novel TARP Inhibitor, in Drug-resistant Epilepsy: A Double-blind Randomized Placebo Controlled Phase IIa Trial Terence J. O'Brien, MD
04:06 PM - 04:18 PM MDT	Abstract	004 - The Impact of Disease Severity on Responder Rates in a Phase 2b Study of XEN1101, a Potent, Selective Potassium Channel Opener, in Adults with Focal Epilepsy (X-TOLE) Roger J. Porter, MD, FAAN
04:18 PM - 04:30 PM MDT	Abstract	005 - Interim Long-term Safety and Efficacy of XEN1101, a Potent, Selective Potassium Channel Opener: Update from an Ongoing Open-label Extension of a Phase 2b Study (X-TOLE) in Adults with Focal Epilepsy Jacqueline French, MD, FAAN
04:30 PM - 04:42 PM MDT	Abstract	006 - Sex Steroid Hormone Serum Concentrations in Pregnant Women with Epilepsy in MONEAD Paula E. Voinescu, MD
04:42 PM - 04:54 PM MDT	Abstract	007 - Verbal Abilities at Age 6-years-old of Children of Women with vs. Without Epilepsy in the MONEAD Study Kimford J. Meador, MD, FAAN
04:54 PM - 05:06 PM MDT	Abstract	008 - Risk and Onset Latency of Incident (New-onset) Epilepsy After Stroke in Post-9/11 U.S. Veterans: A Post-hoc Analysis of the Long-term Impact of Military-relevant Brain Injury Consortium (LIMBIC-CENC) Study Data Manaz Rezayee
05:06 PM - 05:18 PM MDT	Abstract	009 - Acute Seizures After Spontaneous Intracerebral Hemorrhage in Young Individuals: 11-year Trends and Association with Mortality Alain Z. Lekoubou Looti, MD
05:18 PM - 05:30 PM MDT	Abstract	010 - New-onset Vascular Events in Older People with Epilepsy Over Six Years: A Cohort Study of the Canadian Longitudinal Study on Aging (CLSA) Jimmy Li, MD

Faculty Disclosures
Brin Freund, MD	Dr. Freund has received research support from Mayo Clinic.
Babak Razavi, MD, PhD	Dr. Razavi has stock in CortexXus. The institution of Dr. Razavi has received research support from Neuropace.
Erin C. Conrad, MD	Dr. Conrad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder. Dr. Conrad has stock in Humana. Dr. Conrad has stock in Lilly Eli. Dr. Conrad has stock in Medtronic. Dr. Conrad has stock in Merck. Dr. Conrad has stock in Nevro. Dr. Conrad has stock in Sanofi. Dr. Conrad has stock in United Health Group.
	No disclosure on file
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
Roger J. Porter, MD, FAAN	Dr. Porter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axonis. Dr. Porter has received publishing royalties from a publication relating to health care.
Emilio Perucca	No disclosure on file
Martin Brodie	No disclosure on file
Michael A. Rogawski, MD, PhD	Dr. Rogawski has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Xenon Pharmaceuticals.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Jenny Qian	No disclosure on file
Constanza Luzon	Constanza Luzon has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Constanza Luzon has stock in Xenon Pharmaceuticals.
Christopher Kenney	No disclosure on file
Gregory N. Beatch, PhD	Dr. Beatch has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Beatch has stock in Xenon Pharmaceuticals Inc. Dr. Beatch has received intellectual property interests from a discovery or technology relating to health care.
Kimford J. Meador, MD, FAAN	The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from Eisai. The institution of Dr. Meador has received research support from Medtronics. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Morris Cohen	No disclosure on file
David W. Loring, PhD, FAAN	Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE. The institution of Dr. Loring has received research support from NIH. Dr. Loring has received publishing royalties from a publication relating to health care.
Carrie Brown	No disclosure on file
Chelsea Robalino	No disclosure on file
Abigail Matthews	No disclosure on file
Page B. Pennell, MD, FAAN	The institution of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Department of Defense. The institution of an immediate family member of Dr. Pennell has received research support from Environmental Protection Agency. The institution of an immediate family member of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Advanced Energy Consortium. Dr. Pennell has received publishing royalties from a publication relating to health care.
Andrea Carmack	No disclosure on file
Paula E. Voinescu, MD	The institution of Dr. Voinescu has received research support from Epilepsy Foundation of New England. The institution of Dr. Voinescu has received research support from BWH - Connors Center. The institution of an immediate family member of Dr. Voinescu has received research support from American Epilepsy Society. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Physicians' Education Resouce. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Phillipines League Against Epilepsy. Dr. Voinescu has a non-compensated relationship as a Board Member and Chair with My Epilepsy Story that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Speaker with Epilepsy Foundation that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with Epilepsy Ireland that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Member of Scientific Advisory Committee with North American AED Pregnancy Registry that is relevant to AAN interests or activities.
Alison M. Pack, MD, FAAN	An immediate family member of Dr. Pack has received personal compensation for serving as an employee of REGENEXBIO. The institution of Dr. Pack has received research support from National Institutes of Health. Dr. Pack has received publishing royalties from a publication relating to health care.
Elizabeth Gerard, MD	Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of an immediate family member of Dr. Gerard has received research support from Novo Nordisk. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University).
Laura A. Kalayjian, MD	The institution of Dr. Kalayjian has received research support from NIH.
Angela K. Birnbaum, PhD	The institution of Dr. Birnbaum has received research support from National Institutes of Health. The institution of Dr. Birnbaum has received research support from Randy Shaver Cancer and Research Foundation. Dr. Birnbaum has received intellectual property interests from a discovery or technology relating to health care.
Alice Henning	No disclosure on file
Fenny L. Yudiarto, MD, PhD, FAAN	Dr. Yudiarto has nothing to disclose.
Harish Babu	No disclosure on file
Robert Beach, MD, PhD, FAAN	The institution of Dr. Beach has received research support from Neurona.
Sharona Ben-Haim	No disclosure on file
Kim Burchiel	No disclosure on file
Matthew W. Luedke, MD	Dr. Luedke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bright Health. Dr. Luedke has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Guidepoint. The institution of Dr. Luedke has received research support from US NAVY. The institution of Dr. Luedke has received research support from Neurona. The institution of Dr. Luedke has received research support from Xenon.
Rebecca O'Dwyer, MD	Dr. O'Dwyer has nothing to disclose.
Sepehr Sani	No disclosure on file
Jerry J. Shih, MD, FAAN	Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Shih has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Shih has received research support from Neurona. The institution of Dr. Shih has received research support from NCGS, Inc. Dr. Shih has a non-compensated relationship as a Test Writing Committee Member with ABPN that is relevant to AAN interests or activities.
Derek Southwell	No disclosure on file
David C. Spencer, MD, FAAN	Dr. Spencer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace Inc. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. Dr. Spencer has received publishing royalties from a publication relating to health care. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Faculty in Teaching Course supported by unrestricted educational grants with Creative Education Concepts.
Gautam Banik	No disclosure on file
Marina Bershteyn	No disclosure on file
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Alessandro Bulfone, MD	Dr. Bulfone has received personal compensation for serving as an employee of Neurona Therapeutics Inc.
Brianna Feld	No disclosure on file
Holly Finefrock	Ms. Finefrock has received personal compensation for serving as an employee of Neurona Therapeutics.
Luis Fuentealba	No disclosure on file
John D. Hixson, MD	Dr. Hixson has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Hixson has received personal compensation for serving as an employee of Nile Ai. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NextSense Inc.. Dr. Hixson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seer Medical. Dr. Hixson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute.
Victoria Hosford	No disclosure on file
Ji-Hye Jung	No disclosure on file
Tia Kowal	No disclosure on file
Sonja Kriks	No disclosure on file
Rose Larios	No disclosure on file
Seonok Lee	No disclosure on file
Sheri Madrid	No disclosure on file
Yves Maury	No disclosure on file
Catherine Priest	No disclosure on file
Kiril Shevchuk	No disclosure on file
Sergei Shevchuk	No disclosure on file
Cory R. Nicholas, PhD	Dr. Nicholas has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Nicholas has stock in Neurona Therapeutics. Dr. Nicholas has received intellectual property interests from a discovery or technology relating to health care.
Alain Z. Lekoubou Looti, MD	Dr. Lekoubou Looti has nothing to disclose.
Austin Cohrs	No disclosure on file
Darwin Amir, MD, FAAN	No disclosure on file
Terence J. O'Brien, MD	The institution of Prof. O'Brien has received research support from Eisai. The institution of Prof. O'Brien has received research support from UCB. The institution of Prof. O'Brien has received research support from BioGen. The institution of Prof. O'Brien has received research support from ES Theraputics. The institution of an immediate family member of Prof. O'Brien has received research support from Epidarex.
Emma Foster, MD, MBBS	The institution of Dr. Foster has received research support from Monash University Bridging Postdoctoral Fellowship. The institution of Dr. Foster has received research support from Sylvia and Charles Viertel Charitable Foundation. The institution of Dr. Foster has received research support from Brain Foundation (Australia). The institution of Dr. Foster has received research support from Australian Epilepsy Research Fund. The institution of Dr. Foster has received research support from LivaNova. The institution of Dr. Foster has received research support from Lundbeck Australia.
Lyn Millist	No disclosure on file
Jack Germaine	No disclosure on file
Stephanie Chamorro	No disclosure on file
Caitlin Roberts	No disclosure on file
John-Paul Nicolo, MBBS	Dr. Nicolo has nothing to disclose.
Sean Sean	No disclosure on file
Piero Perucca, MD	The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Perucca has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. The institution of Dr. Perucca has received research support from NHMRC. The institution of Dr. Perucca has received research support from Epilepsy Foundation. The institution of Dr. Perucca has received research support from Monash University. The institution of Dr. Perucca has received research support from Sanming Project Grant, Shenzhen government. The institution of Dr. Perucca has received research support from Medical Research Future Fund. The institution of Dr. Perucca has received research support from Norman Beischer Medical Research Foundation. The institution of Dr. Perucca has received research support from NHMRC. The institution of Dr. Perucca has received research support from Austin Medical Research Foundation. The institution of Dr. Perucca has received research support from The University of Melbourne and The University of Bonn. The institution of Dr. Perucca has received research support from Austin Medical Research Foundation . Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Eisai. Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving as a Speaker with UCB. Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving as a Speaker with LivaNova. Dr. Perucca has a non-compensated relationship as a Member, Central Project Commission with EURAP-International Registry of Antiepileptic Drugs and Pregnancy that is relevant to AAN interests or activities. Dr. Perucca has a non-compensated relationship as a Member, Advisory Board with Raoul Wallenberg Australian Pregnancy Register of Antiepileptic Drugs that is relevant to AAN interests or activities.
Saul Mullen	No disclosure on file
Heather Robinson	No disclosure on file
Rebecca Wharrie	No disclosure on file
Brittany Walsh	No disclosure on file
David C. Reutens, MD	The institution of Dr. Reutens has received research support from Australian Research Council. The institution of Dr. Reutens has received research support from Siemens Health Care. The institution of Dr. Reutens has received research support from Vivazone Pty Ltd. Dr. Reutens has received intellectual property interests from a discovery or technology relating to health care.
Kimberley Irwin	No disclosure on file
Michael Chen	No disclosure on file
Robert Niecestro	No disclosure on file
Jacqueline Hirschey, MD	Dr. Hirschey has nothing to disclose.
Megan Amuan	No disclosure on file
Zulfi Haneef, MD, MBBS, MRCP, FAAN	Dr. Haneef has nothing to disclose.
Linda S. Williams, MD, FAAN	The institution of Dr. Williams has received research support from VA HSR&D.
Ian Stewart	No disclosure on file
Marissa Kellogg, MD, MPH	Dr. Kellogg has nothing to disclose.
Mary Jo Pugh, PhD, RN, FAAN	The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs. The institution of Dr. Pugh has received research support from Sanofi.
Elisabeth Wilde	Elisabeth Wilde has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuropsychology. The institution of Elisabeth Wilde has received research support from CDMRP/DoD. The institution of Elisabeth Wilde has received research support from VA. The institution of Elisabeth Wilde has received research support from NIH. The institution of Elisabeth Wilde has received research support from Cohen Veteran Biosciences.
Eamonn Kennedy	No disclosure on file
Manaz Rezayee	Ms. Rezayee has nothing to disclose.
Jale Agaoglu, MD	No disclosure on file
Jimmy Li, MD	Dr. Li has received research support from Fonds de recherche du Québec - Santé. Dr. Li has received research support from Brain Canada.
Nathan Shlobin	No disclosure on file
Roland Thijs	No disclosure on file
Charles Deacon, MD	Dr. Deacon has nothing to disclose.
Mark R. Keezer, MD, PhD	The institution of Dr. Keezer has received research support from UCB . The institution of Dr. Keezer has received research support from Eisai. The institution of Dr. Keezer has received research support from TD Bank. The institution of Dr. Keezer has received research support from Savoy Foundation. The institution of Dr. Keezer has received research support from TSC Alliance. The institution of Dr. Keezer has received research support from Quebec Bio-imaging Network. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research. The institution of Dr. Keezer has received research support from Fonds de Recherche Québec Santé. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research.